Detail
LncRNA Name | EZR-AS1 |
Synonyms | NA |
Region | GRCh38_6:158818011-158820593 Sequence |
Ensembl | ENSG00000233893 |
RefSeq | NR_102425 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✘ |
MiRNA | ✘ |
Variant | ✔ |
TF | ✔ |
Methylation | ✔ |
Cancer Name | esophageal squamous cell cancer |
ICD-0-3 | |
Methods | RNA-seq, qRT-PCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP |
Sample | esophageal squamous cell carcinoma (ESCC) tissues and cell lines (KYSE150 and KYSE510) |
Expression Pattern | up-regulated |
Function Description | Both in vivo and in vitro studies revealed that EZR-AS1 promoted cell migration through up-regulation of EZR expression. Mechanistically, antisense lncRNA EZR-AS1 formed a complex with RNA polymerase II to activate the transcription of EZR. Moreover, EZR-AS1 could recruit SMYD3 to a binding site, present in a GC-rich region downstream of the EZR promoter, causing the binding of SMYD3 and local enrichment of H3K4me3. Finally, the interaction of EZR-AS1 with SMYD3 further enhanced EZR transcription and expression. Our findings suggest that antisense lncRNA EZR-AS1, as a member of an RNA polymerase complex and through enhanced SMYD3-dependent H3K4 methylation, plays an important role in enhancing transcription of the EZR gene to promote the mobility and invasiveness of human cancer cells.EZR-AS1 regulates EZR transcriptional activity in ESCC cells by interacting with RNA polymerase II, but not by affecting the binding of SP1 and AP-1 transcription factors. the overexpression of EZR-AS1 accompanied the enhanced expression of EZR (variant 1), both at the mRNA and protein levels, in KYSE150 cells (Figure 1H and I). |
Pubmed ID | 29253179 |
Year | 2018 |
Title | The interaction of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in ESCC cells. |
External Links |
Links for EZR-AS1 | GenBank HGNC lncrnadb Noncode |
Links for esophageal squamous cell cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.